Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Intelsius Enhances Patient Safety Products
Thursday, February 13, 2014
Company announces enhancement to ThermoTrek™ range of solutions.

Making Scientific Images Publication Ready
Saturday, February 08, 2014
New mini library of I&A Photoshop Add-ons™ from Imaging & Analysis, LLC.

Short Term Storage of Blood or Urine Samples
Thursday, February 06, 2014
Novitain TPE Push Caps offer an ideal solution for the secure short-term sealing of tubes.

Phasefocus Announces the Availability of the VL Series of Live Cell Imaging Systems
Wednesday, February 05, 2014
A family of phase microscopy systems for live cell imaging.

CryoFreeze® – Range of tubes, racks and accessories for use in cryogenic preparation and storage
Tuesday, February 04, 2014
SSI has launched a comprehensive family of cryogenic storage products designed to provide researchers with consumables needed in the cryopreservation of tissue and cells.

Intelsius Introduces Revised PharmaTherm™ Solutions
Wednesday, January 29, 2014
Company introduces PharmaTherm™ solutions at the 13th Annual Cool Chain Europe Summit in Luxembourg.

Brooks Introduces Next-Generation Automated Sample Storage Systems
Wednesday, January 22, 2014
Feature-rich, flexible, reliable technology in a standardized platform.

Fluxion Biosciences Releases IsoFlux Rare Cell Enrichment Kit
Tuesday, January 21, 2014
New bead chemistry enables more options for targeted cell enrichment.

Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells
Tuesday, January 14, 2014
Novel reagent formulation allows researchers to develop assays in more cell lines of interest

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 484
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv